Signaturefd LLC Purchases 255 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Posted by Defense World Staff on Apr 13th, 2023

Signaturefd LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 10.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,665 shares of the company’s stock after buying an additional 255 shares during the quarter. Signaturefd LLC’s holdings in HCA Healthcare were worth $639,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. RFP Financial Group LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at approximately $28,000. Private Trust Co. NA bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at approximately $33,000. Eagle Bay Advisors LLC grew its holdings in shares of HCA Healthcare by 56.7% during the 3rd quarter. Eagle Bay Advisors LLC now owns 210 shares of the company’s stock valued at $39,000 after purchasing an additional 76 shares during the last quarter. Old North State Trust LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $40,000. Finally, Riverview Trust Co acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $42,000. 64.60% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, SVP P. Martin Paslick sold 2,539 shares of HCA Healthcare stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $270.00, for a total value of $685,530.00. Following the sale, the senior vice president now owns 24,643 shares of the company’s stock, valued at $6,653,610. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other HCA Healthcare news, SVP P. Martin Paslick sold 2,539 shares of HCA Healthcare stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $270.00, for a total value of $685,530.00. Following the sale, the senior vice president now owns 24,643 shares of the company’s stock, valued at $6,653,610. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Bill B. Rutherford sold 30,000 shares of HCA Healthcare stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $258.19, for a total transaction of $7,745,700.00. Following the completion of the sale, the chief financial officer now directly owns 81,632 shares in the company, valued at approximately $21,076,566.08. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 85,472 shares of company stock worth $21,950,034. 1.60% of the stock is owned by insiders.

HCA Healthcare Trading Up 0.3 %

Shares of HCA stock opened at $272.38 on Thursday. The firm has a market capitalization of $75.52 billion, a PE ratio of 14.16, a price-to-earnings-growth ratio of 1.94 and a beta of 1.64. The firm has a fifty day simple moving average of $256.48 and a two-hundred day simple moving average of $239.09. HCA Healthcare, Inc. has a 12 month low of $164.47 and a 12 month high of $279.02.

HCA Healthcare (NYSE:HCA – Get Rating) last released its quarterly earnings results on Friday, January 27th. The company reported $4.64 earnings per share for the quarter, missing the consensus estimate of $4.79 by ($0.15). HCA Healthcare had a negative return on equity of 1,260.96% and a net margin of 9.37%. The firm had revenue of $15.50 billion for the quarter, compared to analysts’ expectations of $15.51 billion. On average, equities analysts predict that HCA Healthcare, Inc. will post 17.17 earnings per share for the current fiscal year.

HCA Healthcare announced that its board has initiated a stock repurchase plan on Friday, January 27th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 4.2% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 31st. Investors of record on Friday, March 17th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Thursday, March 16th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.56. This represents a $2.40 annualized dividend and a yield of 0.88%. HCA Healthcare’s payout ratio is 12.48%.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $235.00 to $257.00 and gave the stock an “overweight” rating in a research report on Thursday, February 23rd. Raymond James boosted their price target on shares of HCA Healthcare from $230.00 to $300.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 31st. UBS Group boosted their price target on shares of HCA Healthcare from $237.00 to $296.00 and gave the stock a “buy” rating in a research report on Friday, January 13th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, April 5th. Finally, Citigroup boosted their price target on shares of HCA Healthcare from $280.00 to $293.00 and gave the stock a “buy” rating in a research report on Monday, January 30th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $270.27.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.